A short trial to evaluate SNG001 in Chronic Obstructive Pulmonary Disease (COPD).
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 04 Oct 2017 New trial record
- 27 Sep 2017 According to a Synairgen media release, this trial is being submitted for regulatory approval.